azomycin has been researched along with nsc 4347 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastos, JK; Cunha, WR; da Silva Ferreira, D; de Albuquerque, S; e Silva, ML; Esperandim, VR; Rezende, KC; Saraiva, J | 1 |
| de Araujo, AC; De Mattos, JC; García-Huertas, PA; Hamedt, AL; Ortiz, IC; Rodríguez-Gazquez, MA; Sáenz, J; Triana-Chávez, O | 1 |
2 other study(ies) available for azomycin and nsc 4347
| Article | Year |
|---|---|
Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; Chagas Disease; Dioxoles; Lignans; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Piper; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
Cytotoxic, mutagenic and genotoxic evaluation of crude extracts and fractions from Piper jericoense with trypanocidal action.
Topics: Cell Survival; Cells, Cultured; Chemical Fractionation; Culture Media; Humans; Life Cycle Stages; Lymphocytes; Mutagenicity Tests; Nifurtimox; Nitroimidazoles; Parasitic Sensitivity Tests; Piper; Plant Extracts; Trypanocidal Agents; Trypanosoma cruzi | 2014 |